From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Gastroenterology>
  4. Summary and Comment

Predicting Mortality in Patients with Severe Acute Pancreatitis

A simple new scoring system proved both sensitive and specific for mortality.

In patients with severe acute pancreatitis, identifying risk for mortality within 24 hours of presentation is critical. However, a simple scoring system to predict mortality based on routine laboratory and diagnostic test results has been lacking.

To provide such a system, investigators developed and prospectively evaluated the performance of a bedside index for severity in acute pancreatitis (BISAP) in 397 consecutive cases of acute pancreatitis at a tertiary care hospital. BISAP is scored on a scale of 0 to 5, based on how many of the following characteristics the patient has within 24 hours of presentation: blood urea nitrogen level >25 mg/dL, impaired mental status, systemic inflammatory response syndrome, age >60, and pleural effusion on imaging studies.

Organ failure occurred within 72 hours of presentation in 18% of cases (transient in 74%), and the overall 1-week mortality rate was 3.5%. The higher the BISAP score was, the greater the mortality rate (P for trend, <0.0001). A score of 3 was determined to be the optimal cutoff for predicting mortality: Death occurred in 18% of cases with BISAP scores ≥3 versus 1% of cases with scores <3. In terms of mortality, a BISAP score ≥3 had a sensitivity of 71%, a specificity of 83%, a positive predictive value of 18%, and a negative predictive value (NPV) of 99%. In addition, a BISAP score ≥3 was significantly associated with increased risk for organ failure overall (odds ratio, 7.4), persistent organ failure (OR, 12.7), and pancreatic necrosis (OR, 3.8).

Comment: The main advantage of the BISAP scoring system over others is its simplicity: Scores can be calculated quickly using easily accessible data. Its NPV for mortality (99%) is impressive. This study was conducted in a tertiary care setting with experts in all aspects of patient care. If the results are confirmed in a community setting, BISAP will likely become the standard prognostic scoring system to identify patients at risk for mortality and organ failure.

Stuart Sherman, MD

Published in Journal Watch Gastroenterology September 18, 2009

Citation(s):

Singh VK et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol 2009 Apr; 104:966.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Related Content

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.